Efficacy of Modified Constraint-Induced Movement Therapy combined with Robotic Therapy for patients with upper limb paralysis after stroke

Efficacy of Modified Constraint-Induced Movement Therapy combined with Robotic Therapy for patients with upper limb paralysis after stroke - Efficacy of Modified Constraint-Induced Movement Therapy combined with Robotic Therapy for patients with upper limb paralysis after stroke

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034191

Enrollment

Registered

2018-09-18

Start date

2017-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

We provide Modified Constraint-Induced Movement Therapy(Modified CIMT) and self-training using ReoGo-J during six weeks for patients with upper limb paralysis after stroke. Each treatment is provided

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Clinically incipient stroke patients with upper-limb hemiplegia (2)Patients who experienced a stroke in the previous 4 to 8 weeks 4. (3)Upper-limb(shoulder/elbow)Brunnstrom stage III or IV at the time of providing informed consent (4) Age between 20 and 80 years at the time of providing informed consent (5) Patients who can do self-care themselves at a sitting position

Exclusion criteria

Exclusion criteria: (1)Brainstem stroke (2)Vision disorders (3)Subarachnoid hemorrhage (4)Severe aphasia (5)Mini-mental state examination less than 24 points (6) Inability to remain seated during training (7) Intense pain in response to external pressure on affected upper limb (8) Incapable of voluntary consent (9) Previous experience with robotic rehabilitation of upper-limb hemiplegia (10) Previous experience with constraint-induced movement therapy of upper-limb hemiplegia (11) Previous experience with functional electrical stimulation(FES)therapy of upper limb hemiplegia (12) Cardiac or respiratory disorders that may interfere with rehabilitation (13) Other neuromuscular diseases (14) Body weight of 110 kg or more (15) Other reasons deemed by the investigators or subinvestigators to render the subject unsuitable for treatment with the investigational device

Design outcomes

Primary

Measure	Time frame
Fugl-Meyer Assessment(FMA)Upper extremity section Each outcome is evaluated at baseline(before any rehabilitation), after 3-week, after 6-week(after any rehabilitation)	—

Secondary

Measure	Time frame
Upper-limb/Finger Brunnstrom stage Simple test for evaluation hand function(STEF) pain:100mm Visual analogue scale(VAS)	—

Countries

Japan

Contacts

Public ContactNaoya Anmoto

Nagoya city rehabilitation agency Division of occupational therapy

ot-dep@nagoya-rehab.or.jp052-835-3811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026